Recent Articles

Trying to lose weight? Be careful not to lose muscle

Is your skin problem actually an autoimmune condition?

People with diabetes face higher risk of hearing loss

Antibiotic-free fixes for recurrent UTIs

Musculoskeletal syndrome of menopause: When menopause makes you ache all over

When can older women stop getting mammograms?

To lose weight, especially harmful belly fat, combine diet and exercise

Can men hold off on treating recurring prostate cancer?

The 7 types of rest and why we need them all

What are the early warning signs of cervical cancer?

For "bad" cholesterol, lower is better; dual drug therapy may help

High cholesterol, in particular high low-density lipoprotein (LDL), the so-called bad cholesterol, is a key cause of heart disease. A large clinical trial called IMPROVE-IT set out in 2005 to answer two key questions about LDL:

How low should drug therapy drive LDL?
Can drugs other than statins, the gold standard for lowering cholesterol, help?

The results of IMPROVE-IT were recently published in The New England Journal of Medicine.

Dr. Deepak L. Bhatt, Editor in Chief of the Harvard Heart Letter, talked about the significance of the IMPROVE-IT findings with Dr. Christopher P. Cannon, the trial's lead investigator, and Dr. John A. Jarcho, an editor of The New England Journal of Medicine.

Print This Page

Disclaimer:

As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.

No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.